BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2302660)

  • 1. Role of the gallium scan in Hodgkin's disease.
    Hagemeister FB; Fesus SM; Lamki LM; Haynie TP
    Cancer; 1990 Mar; 65(5):1090-6. PubMed ID: 2302660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose gallium imaging in lymphoma.
    Anderson KC; Leonard RC; Canellos GP; Skarin AT; Kaplan WD
    Am J Med; 1983 Aug; 75(2):327-31. PubMed ID: 6881185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gallium scan in recurrent Hodgkin's disease in children.
    Yeh SD; Benua RS; Tan CT
    Clin Nucl Med; 1979 Sep; 4(9):359-67. PubMed ID: 477163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three cases demonstrating the role of gallium scanning in relapsing Hodgkin's disease and non-Hodgkin lymphoma.
    Zollars LE; Nagel JS; Tumeh SS
    J Nucl Med; 1987 Oct; 28(10):1611-5. PubMed ID: 3655913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restaging with gallium scan identifies chemosensitive patients and predicts survival of poor-prognosis mediastinal Hodgkin's disease patients.
    Ionescu I; Brice P; Simon D; Guermazi A; Leblanc T; Rousselot P; Gossot D; Meignin V; Gisselbrecht C; Rain JD
    Med Oncol; 2000 May; 17(2):127-34. PubMed ID: 10871819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallium-67 scans as an adjunct to computed tomography scans for the assessment of a residual mediastinal mass in pediatric patients with Hodgkin's disease. A Pediatric Oncology Group study.
    Weiner M; Leventhal B; Cantor A; Wimmer R; Berry DL; Cook B; Ducos R
    Cancer; 1991 Dec; 68(11):2478-80. PubMed ID: 1933785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic importance of restaging gallium scans following induction chemotherapy for advanced Hodgkin's disease.
    King SC; Reiman RJ; Prosnitz LR
    J Clin Oncol; 1994 Feb; 12(2):306-11. PubMed ID: 8113837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallium scanning in the management of mediastinal Hodgkin's disease.
    Wylie BR; Southee AE; Joshua DE; McLaughlin AF; Gibson J; Hutton BF; Morris JG; Kronenberg H
    Eur J Haematol; 1989 Apr; 42(4):344-7. PubMed ID: 2721659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gallium scans in patients with mediastinal Hodgkin's disease treated with chemotherapy.
    Cooper DL; Caride VJ; Zloty M; Germino J; Farber LR; Hoffer PB
    J Clin Oncol; 1993 Jun; 11(6):1092-8. PubMed ID: 8501495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beguiled by the gallium. Thymic rebound in an adult after chemotherapy for Hodgkin's disease.
    Burns DE; Schiffman FJ
    Chest; 1993 Dec; 104(6):1916-9. PubMed ID: 8252989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallium scan in adolescents and children with Hodgkin's disease (HD). Treatment response assessment and prognostic value.
    Castellani MR; Cefalo G; Terenziani M; Aliberti G; Maccauro M; Alessi A; Villano C; Bombardieri E
    Q J Nucl Med; 2003 Mar; 47(1):22-30. PubMed ID: 12714951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease.
    Devizzi L; Maffioli L; Bonfante V; Viviani S; Balzarini L; Gasparini M; Valagussa P; Bombardieri E; Santoro A; Bonadonna G
    Ann Oncol; 1997; 8 Suppl 1():53-6. PubMed ID: 9187430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gallium scans in the management of patients with Hodgkin's disease: a study of 101 patients.
    Salloum E; Brandt DS; Caride VJ; Cornelius E; Zelterman D; Schubert W; Mannino T; Cooper DL
    J Clin Oncol; 1997 Feb; 15(2):518-27. PubMed ID: 9053473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mid- and post-ABVD gallium scanning predicts for recurrence in early-stage Hodgkin's disease.
    Ng AK; Bernardo MV; Silver B; Van Den Abbeele A; Stevenson MA; Fisher DC; Mauch PM
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):175-84. PubMed ID: 15629609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of high dose 67-gallium scintigraphy in staging untreated patients with lymphoma.
    Larcos G; Farlow DC; Antico VF; Gruenewald SM; Boyages J
    Aust N Z J Med; 1994 Feb; 24(1):5-8. PubMed ID: 8002858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallium-67 scintigraphy in the management: Hodgkin's disease and non-Hodgkin's lymphoma.
    Rehm PK
    Cancer Biother Radiopharm; 1999 Aug; 14(4):251-62. PubMed ID: 10850311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relative roles of gallium-67-citrate scanning and lymphangiography in the current management of malignant lymphoma.
    Rudders RA; McCaffrey JA; Kahn PC
    Cancer; 1977 Oct; 40(4):1439-43. PubMed ID: 907962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic efficiency of gallium 67 citrate scans in Hodgkin's disease.
    Kotlyarov EV; Elson JD; Quaife MA
    Ann Clin Lab Sci; 1981; 11(2):173-9. PubMed ID: 7259092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of gallium imaging after therapy for Hodgkin's disease.
    Bogart JA; Chung CT; Mariados NF; Vermont AI; Lemke SM; Grethlein S; Graziano SL
    Cancer; 1998 Feb; 82(4):754-9. PubMed ID: 9477109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of gallium 67 scanning in the management of Hodgkin's disease.
    Raby N; Ineson N
    Br J Clin Pract; 1987 Jan; 41(1):553-6. PubMed ID: 3663456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.